Clinical Trials on 乳腺癌,男性 in New Zealand
总计8835个结果
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Cedars-Sinai Medical Center完全的
-
Rutgers, The State University of New Jersey主动,不招人
-
BriaCell Therapeutics CorporationLumaBridge邀请报名
-
Roswell Park Cancer InstitutePfizer完全的
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey终止
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense; Genentech, Inc.完全的
-
EpiAxis TherapeuticsThe Canberra Hospital; Southern Medical Day Care Centre; Liverpool Cancer Therapy Centre完全的
-
Washington University School of MedicinePfizer; Rising Tide Foundation终止
-
Nancy Chan, MDMerck Sharp & Dohme LLC主动,不招人
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); University of Rochester; University of Massachusetts, Boston完全的
-
Weill Medical College of Cornell UniversityUniversity of California, Los Angeles完全的
-
Tracon Pharmaceuticals Inc.United States Department of Defense; Roswell Park Cancer Institute完全的
-
St Vincent's Hospital招聘中
-
Memorial Sloan Kettering Cancer CenterBrigham and Women's Hospital; Weill Medical College of Cornell University; The City College of... 和其他合作者完全的
-
Rutgers, The State University of New JerseyLudwig Institute for Cancer Research尚未招聘
-
Canadian Cancer Trials GroupHoffmann-La Roche主动,不招人
-
Massachusetts General HospitalAstraZeneca; OncoPep, Inc.主动,不招人
-
Sanofi完全的
-
Memorial Sloan Kettering Cancer Center完全的
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Cianna Medical, Inc.终止I期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIC期乳腺癌 | 小叶乳腺癌原位癌 | 雌激素受体阴性 | 雌激素受体阳性 | HER2/Neu 阴性 | 孕激素受体阳性 | 乳腺导管原位癌 | 粘液性乳腺癌 | 管状乳腺癌 | 浸润性导管癌,未另行说明 | 浸润性筛状乳腺癌 | 乳头状乳腺癌美国
-
AstraZeneca完全的
-
Synermore Biologics Co., Ltd.完全的Colon Cancer, Breast Cancer, Cancer of the Head and Neck美国
-
Mayo ClinicNational Cancer Institute (NCI)主动,不招人IV 期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 浸润性乳腺癌 | IIIC期乳腺癌 | HER2/Neu 阴性 | III期乳腺癌 | 绝经后 | 雌激素受体状态美国
-
Bolt Biotherapeutics, Inc.Hoffmann-La Roche主动,不招人
-
National Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterMemorial University Medical Center主动,不招人
-
Rutgers, The State University of New JerseyRutgers Cancer Institute of New Jersey; Elekta Limited; Cianna Medical, Inc.完全的浸润性乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | 雌激素受体阳性 | 孕激素受体阳性 | 乳腺导管原位癌美国
-
Memorial Sloan Kettering Cancer CenterStryker Instruments; pHLIP Inc.招聘中
-
Dana-Farber Cancer InstituteJohns Hopkins University; GlaxoSmithKline; Translational Breast Cancer Research Consortium招聘中乳腺癌 | I期乳腺癌 | II期乳腺癌 | HER2 阴性乳腺癌 | III期乳腺癌 | 有害的 PALB2 基因突变 | 种系 BRCA1 基因突变 | 种系 BRCA2 基因突变美国
-
Infinity Pharmaceuticals, Inc.终止
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of Defense招聘中
-
National Cancer Institute (NCI)主动,不招人恶性实体肿瘤 | 解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 浸润性乳腺癌 | 乳腺癌美国
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)尚未招聘
-
Dana-Farber Cancer InstituteMacroGenics; Translational Breast Cancer Research Consortium主动,不招人
-
Northwestern UniversityNational Cancer Institute (NCI)完全的0 期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | 小叶乳腺癌原位癌 | 乳腺导管原位癌 | BRCA1突变携带者 | BRCA2突变携带者美国